Evidence map›Paper›PMID 37207002›Full record

ArticleVirus evolution2023

Tracking the emergence of antigenic variants in influenza A virus epidemics in Brazil.

Tara K Pillai, Katherine E Johnson, Timothy Song, Tatiana S Gregianini, Baccin Tatiana G, Guojun Wang, Rafael A Medina, Harm Van Bakel, Adolfo García-Sastre, Martha I Nelson and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Virus evolution, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Tara K PillaiSystems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, 50 South Drive, Bethesda, MD 20894, USA.
Katherine E JohnsonSystems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, 50 South Drive, Bethesda, MD 20894, USA.
Timothy SongDepartment of Biology, Center for Genomics & Systems Biology, New York University, 12 Waverly Place, New York, NY 10003, USA.
Tatiana S GregianiniLaboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul-LACEN/CEVS/SES-RS, Av. Ipiranga, 5400, Porto Alegre, RS 90450-190, Brazil.
Baccin Tatiana GGraduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite, 245, Rio Grande do Sul, RS 90050-170, Brazil.
Guojun WangDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.
Rafael A MedinaDepartment of Pediatric Infectious Diseases and Immunology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago, RM 8330024, Chile.
Harm Van BakelLaboratory of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY 10029, USA.ORCID https://orcid.org/0000-0002-1376-6916
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.
Martha I NelsonSystems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, 50 South Drive, Bethesda, MD 20894, USA.
Elodie GhedinSystems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, 50 South Drive, Bethesda, MD 20894, USA.
Ana B G VeigaGraduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite, 245, Rio Grande do Sul, RS 90050-170, Brazil.ORCID https://orcid.org/0000-0003-1462-5506
Mount Sinai Hospital · USNational Institute of Allergy and Infectious Diseases · USEmory University · USNational Center for Biotechnology Information · USNew York University · USSecretaria da Saúde · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Genomic profiling of influenza infections to identify biomarkers of disease severityZIAAI001323 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GHEDIN, ELODIE · 2020 to 2025
$8.0M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
NCATS NIH HHS UL1 TR004419NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

Influenza A virus (IAV) circulation patterns differ in North America and South America, with influenza seasons often characterized by different subtypes and strains. However, South America is relatively undersampled considering the size of its population. To address this gap, we sequenced the complete genomes of 220 IAVs collected between 2009 and 2016 from hospitalized patients in southern Brazil. New genetic drift variants were introduced into southern Brazil each season from a global gene pool, including four H3N2 clades (3c, 3c2, 3c3, and 3c2a) and five H1N1pdm clades (clades 6, 7, 6b, 6c, and 6b1). In 2016, H1N1pdm viruses belonging to a new 6b1 clade caused a severe influenza epidemic in southern Brazil that arrived early and spread rapidly, peaking mid-autumn. Inhibition assays showed that the A/California/07/2009(H1N1) vaccine strain did not protect well against 6b1 viruses. Phylogenetically, most 6b1 sequences that circulated in southern Brazil belong to a single transmission cluster that rapidly diffused across susceptible populations, leading to the highest levels of influenza hospitalization and mortality seen since the 2009 pandemic. Continuous genomic surveillance is needed to monitor rapidly evolving IAVs for vaccine strain selection and understand their epidemiological impact in understudied regions.

Indexed as

genomic surveillanceinfluenza A virusphylodynamicssevere acute respiratory infectionvirus evolution

Identifiers

PMID37207002
PMCPMC10191192
OpenAlexW4366997532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.